Statin, inflammation, and sepsis

被引：3

作者：

Inoue, K

Takano, H

Yanagisawa, R

Sakurai, A

Yoshikawa, T

机构：

[1] Natl Inst Environm Studies, Inhalat Toxicol Res Team, Tsukuba, Ibaraki 3058506, Japan

[2] Natl Inst Environm Studies, Pathophysiol Res Team, Tsukuba, Ibaraki 3058506, Japan

来源：

CHEST | 2004年 / 125卷 / 06期

关键词：

D O I：

10.1378/chest.125.6.2365

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：2365 / 2365

页数：1

共 9 条

[1] Statins, inflammation, and sepsis - Hypothesis [J].

Almog, Y .

CHEST, 2003, 124 (02) :740-743

[2] Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ12,14-prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis [J].

Diab, A ;

Deng, CS ;

Smith, JD ;

Hussain, RZ ;

Phanavanh, B ;

Lovett-Racke, AE ;

Drew, PD ;

Racke, MK .

JOURNAL OF IMMUNOLOGY, 2002, 168 (05) :2508-2515

[3] Fibrate and statin synergistically increase the transcriptional activities of PPARα/RXRα and decrease the transactivation of NFκB [J].

Inoue, I ;

Itoh, F ;

Aoyagi, S ;

Tazawa, S ;

Kusama, H ;

Akahane, M ;

Mastunaga, T ;

Hayashi, K ;

Awata, T ;

Komoda, T ;

Katayama, S .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (01) :131-139

[4] Effect of 15-deoxy-Δ12,14-prostaglandin J2 on acute lung injury induced by lipopolysaccharide in mice [J].

Inoue, KI ;

Takano, H ;

Yanagisawa, R ;

Morita, M ;

Ichinose, T ;

Sadakane, K ;

Yoshino, S ;

Yamaki, K ;

Kumagai, Y ;

Uchiyama, K ;

Yoshikawa, T .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 481 (2-3) :261-269

[5] 15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats [J].

Kawahito, Y ;

Kondo, M ;

Tsubouchi, Y ;

Hashiramoto, A ;

Bishop-Bailey, D ;

Inoue, K ;

Kohno, M ;

Yamada, R ;

Hla, T ;

Sano, H .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02) :189-197

[6] Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells [J].

Mulhaupt, F ;

Matter, CM ;

Kwak, BR ;

Pelli, G ;

Veillard, NR ;

Burger, F ;

Graber, P ;

Lüscher, TF ;

Mach, F .

CARDIOVASCULAR RESEARCH, 2003, 59 (03) :755-766

[7] A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response [J].

Su, CG ;

Wen, XM ;

Bailey, ST ;

Jiang, W ;

Rangwala, SM ;

Keilbaugh, SA ;

Flanigan, A ;

Murthy, S ;

Lazar, MA ;

Wu, GD .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :383-389

[8] Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo [J].

Thieringer, R ;

Fenyk-Melody, JE ;

Le Grand, CB ;

Shelton, BA ;

Detmers, PA ;

Somers, EP ;

Carbin, L ;

Moller, DE ;

Wright, SD ;

Berger, J .

JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :1046-1054

[9] Modulation of inflammatory mediators and PPARγ and NFκB expression by pravastatin in response to lipoproteins in human monocytes in vitro [J].

Zelvyte, I ;

Dominaitiene, R ;

Crisby, M ;

Janciauskiene, S .

PHARMACOLOGICAL RESEARCH, 2002, 45 (02) :147-154

← 1 →